Figure 6From: Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor Analysis of c-kit and KIT expression in C2, TR1, TR2, and TR3 cells by RT-qPCR (A) and flow cytometry (B), respectively. Back to article page